SavedAdd your journal

Journals / Anadolu Kardiyoloji Dergisi / 2008 / Cilt: 8 - Sayı: 1

Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis

Kombine heterozigot faktör V Leiden mutasyonu ve antikardiyolipin antikor pozitifliği olan genç bir hastada derin ven trombozu

Nuri KARADURMUŞ
Cengiz ÖZTÜRK
Teoman DOĞRU
Alper SÖNMEZ
Selahattin ERİKÇİ
Cantürk TAŞÇI
Satılmış İNAL
Ahmet ÖZTÜRK
Pages
71–73
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

KARADURMUŞ, N., ÖZTÜRK, C., DOĞRU, T., SÖNMEZ, A., ERİKÇİ, S., TAŞÇI, C., İNAL, S., ÖZTÜRK, A. (2022). Combined heterozygote factor V Leiden mutation and anticardiolipin antibody positivity in a young patient with spontaneous deep vein thrombosis. Anadolu Kardiyoloji Dergisi, Cilt: 8 - Sayı: 1, 71–73. https://ajindex.com/articles/437088

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Nicolaes GA, Dahlback B. Activated protein C resistance (Factor V Leiden) and thrombosis: factor V mutations causing hypercoagulable states. Hematol Oncol Clin North Am 2003;17: 37-61
  2. Price DT, Ridker PM. Factor V Leiden mutation and the risk for thromboembolic disease: a clinical perspective. Ann Intern Med 1997; 127: 895-903
  3. Lensen RP, Rosendaal FR, Koster T, Allaart CF, de Ronde H, Bertina RM. Apparent different thrombotic tendency in patients with factor V Leiden and protein C deficiency due to selection of patients. Blood 1996; 88: 4205-8
  4. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-5
  5. Koeleman BPC, van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families? Thromb Haemost 1995; 74: 580-3
  6. Lensen RPM, Bertina RM, de Ronde H, Vandenbroucke JP, Rosendaal FR. Venous thrombotic risk in family members of unselected individuals with factor V Leiden. Thromb Haemost 2000; 83: 817-21
  7. Lopez FF, Sweeney JD, Blair AJ, Sikov WM. Spontaneous venous thrombosis in a young patient with combined factor V Leiden and lupus anticoagulant. Am J Hematol 1999; 62: 58-60
  8. Wahl DG, Guillemin F, de Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus 1998; 7: 15-22
  9. Bili A, Moss AJ, Francis CW, Zareba W, Watelet LF, Sanz I. Anticardiolipin antibodies and recurrent coronary events: a prospective study of 1150 patients. Thrombogenic Factors, and Recurrent Coronary Events Investigators. Circulation 2000; 102: 1258-63
  10. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997; 89: 2817-21.